Lindsey Anne Compton, PHARMD in Portola, CA - Pharmacist

Lindsey Anne Compton, PHARMD is a Pharmacist based in Portola, California. Lindsey Anne Compton is licensed to practice in California (license number 83047) and her current practice location is 157 Commercial St, Portola, California. She can be reached at her office (for appointments etc.) via phone at (530) 832-4218.

NPI number for Lindsey Anne Compton is 1235741885 and her current mailing address is 160 Rabbit Brush Ave, Portola, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1235741885.

Contact Information

	Lindsey Anne Compton, PHARMD
	157 Commercial St, Portola, CA 96122-9606
	(530) 832-4218
	(530) 832-1375

Healthcare Provider's Profile

Full Name	Lindsey Anne Compton
Gender	Female
Speciality	Pharmacist
Location	157 Commercial St, Portola, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1235741885
Provider Enumeration Date: 08/17/2020
Last Update Date: 06/16/2021

Medical Identifiers

Medical identifiers for Lindsey Anne Compton such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1235741885	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	83047 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lindsey Anne Compton is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Lindsey Anne Compton, PHARMD 160 Rabbit Brush Ave, Portola, CA 96122-6609 Ph: (530) 249-5641	Lindsey Anne Compton, PHARMD 157 Commercial St, Portola, CA 96122-9606 Ph: (530) 832-4218

News Archive

Blog posts address possible global health, foreign policy priorities in second Obama administration

After President Barack Obama's re-election on Tuesday, the following blog posts addressed possible foreign policy priorities during the next administration.

Peanut allergy tolerance treatment may increase the risk of anaphylaxis

Treating children who have a peanut allergy by gradually exposing them to increasing levels of peanut extract may actually increase their risk of allergic attacks, warn researchers.

Researchers look for ways to prevent chemotherapy-induced cognitive impairment

Of the 14 million cancer survivors in the United States, a significant number experience a serious side effect called chemotherapy-induced cognitive impairment (CICI). While easily recognized, little is known about the etiology of this condition, also known informally as "chemo brain."

Multidisciplinary prevention programme not effective in improving perceived employee health

Most of us would agree that prevention is better than cure. But new results out in the journal Clinical Rehabilitation, published by SAGE, indicate that a costly intervention programme designed to reduce early retirement on health grounds in Finland had no measurable effect.

Key finding may point to immediate cause of CF exacerbations

In the genetic disorder cystic fibrosis (CF), the most severe symptoms are recurring episodes of lung inflammation and bacterial infection (known as "exacerbations") that happen from one to three times a year and cause ever-increasing amounts of lung damage through the course of a CF patient's life.

Lindsey Anne Compton, PHARMD - Pharmacist in Portola, CA